Skip to Page Content
CME/CE Expiration Date: 9/01/2021*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

 

Description: 

Medications for Obesity-related Diseases: Become more comfortable incorporating medications for obesity-related diseases into treatment. Dr. Harold Bays will describe conditions related to obesity for which there are therapeutic options and delve into the prescribing details for some of these medications.

 

What's in the Pipeline for Anti-obesity Medications?: Dr. Bays provides an understanding of the anti-obesity agents in development. 

 


 

Accreditation:

The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

The OMA designates this enduring material internet activity for a maximum of 1.75 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Presentation Information
Presentation Date:
September 29, 2018
Expiration Date:
August 31, 2021 12:00 AM
Presentation Location:
Washington, DC
Presentation Objectives
  • Understand obesity as a disease that causes metabolic and cardiovascular diseases
  • Knowledge of supplements and over-the-counter anti-obesity therapies
  • Summarize anti-obesity therapies as stated in the Obesity Algorithm
  • Understand central nervous system targets of anti-obesity therapies
  • Understand gastro-intestinal targets of anti-obesity therapies
  • Understand anti-obesity agents in development
Medications for Obesity-Related Diseases

 

Dr. Bays is Medical Director of L-MARC Research Center and Principal Investigator for over 500 clinical trials, including anti-obesity treatments. He is board certified in internal medicine and endocrinology, Diplomate of the American Board of Obesity Medicine, Diplomate of the American Board of Clinical Lipidology, has authored over 200 peer review articles and 100's of abstracts, and is medical writer of the OMA Obesity Algorithm. He has been awarded Obesity Medicine Clinician of the Year in 2016.

 

 

 

 

 

 

 

What's in the Pipeline for Anti-obesity Medications

 

Dr. Bays is Medical Director of L-MARC Research Center and Principal Investigator for over 500 clinical trials, including anti-obesity treatments. He is board certified in internal medicine and endocrinology, Diplomate of the American Board of Obesity Medicine, Diplomate of the American Board of Clinical Lipidology, has authored over 200 peer review articles and 100's of abstracts, and is medical writer of the OMA Obesity Algorithm. He has been awarded Obesity Medicine Clinician of the Year in 2016.

 

 

 

 

 

 

Individual topic purchase: Selected
Obesity Medicine Association
AMA PRA Category 1 Credit(s)™: 1.75
Participation Credit(s): 1.75
Share This
All Access Subscription
Use for All Access  account holders only
To continue, you need to log in to oma. If you have any questions about your account please contact us at 1-866-702-3278.
Email Address:
Password:
Products
On demand
OMA Member Price:
$35.00
Non Member Price: Become a Member!   $46.00